Table 1.
Demographic variables of feasibility testing participants (n = 9)
| Demographic variable | Frequency of demographic n (%) |
|---|---|
| Age (median years + IQRa) | 31 (29.5–33.5) |
| Ulcerative colitis | 4 (44) |
| Crohn’s disease | 5 (56) |
| Duration of disease (median years + IQR) | 5.5 (3.5–13) |
| Current medications | |
| 5-aminosalicylates | 3 (33) |
| Corticosteroids | 2 (22) |
| Immunomodulator (Thiopurine) | 4 (44) |
| Biologics | 4 (44) |
| Anti-tumour necrosis factor | 4 |
| Vedolizumab | 0 |
| Ustekinumab | 0 |
| Surgical history | |
| Yes | 2 (22) |
| No | 7 (78) |
| Pregnancy stage | |
| Preconception | 3 (33) |
| Pregnancy | 4 (44) |
| Post-partum | 2 (22) |
| Currently breastfeeding | |
| Yes | 2 (22) |
| No | 0 |
| Not applicable | 7 (78) |
| Prior pregnancies (if pregnant, excludes current) | |
| Yes | 5 (56) |
| No | 2 (22) |
| Marital status | |
| Married | 6 (67) |
| Common-law | 1 (11) |
| Single | 2 (22) |
| Highest level of education | |
| High school diploma | 2 (22) |
| Trade, technical, vocational, business school | 1 (11) |
| University undergraduate degree | 3 (33) |
| Post graduate degree | 3 (33) |
| Total income (CAD/AUS $) | |
| 20,000–39,990 | 1 (11) |
| 40,000–69,900 | 1 (11) |
| 70,000–99,000 | 2 (22) |
| 100,000+ | 5 (56) |
aIQR: Interquartile